Pain News NetworkStem Cell Regulation and a Rule Too ManyPain News NetworkThe New England Journal of Medicine recently published an op/ed rather benignly entitled “Rejuvenating Regenerative Medicine Regulation.” The authors, R. Alta Claro and Douglas … Continue reading
|
Commentary: Make way for a brave new world
Naples Daily News Take gene therapy. After years of painfully slow approvals, the Food and Drug Administration OK’d three breakthrough biomeds in 2017. Luxturna is the first therapy that replaces a faulty gene with a healthy one, allowing treatment of a degenerative eye … |
Madison.com |
Better Buy: Intrexon Corporation vs. Celgene
Madison.com Intrexon’s Trans Ova subsidiary focuses on use of genetics in breeding cattle. Another subsidiary, Oxitec, works on biological solutions to control insect populations. Intrexon’s Viagen group targets genetic preservation and cloning technologies. Yet … |
HuffPost UK |
Why I Fought For My Friend’s Right To Have A Second Stem Cell Transplant
HuffPost UK Since that wonderful day we have been contacted by people that have gone on to have second stem cell transplants and it has been heartwarming when they have messaged us thanking us for our fight. But the real hero of this story isn’t me, it’s all the … |
Dallas News (blog) |
Stem–cell therapy has taken a weight off Keone Kela’s shoulder
Dallas News (blog) Kela tried stem–cell therapy to help the shoulder. Cells were removed from bone marrow in another part of the body and injected into the shoulder. Bone-marrow cells are used most often for cartilage, ligament and tendon repair. The treatment is being … |